Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Automating Laboratory-On-A-Chip To Cut Healthcare Costs

Published: Friday, June 20, 2014
Last Updated: Monday, July 07, 2014
Bookmark and Share
Computer programming language automates “laboratory-on-a-chip” technologies and has potential to improve and reduce cost of healthcare.

A research team at the University of California, Riverside has created a computer programming language that will automate “laboratory-on-a-chip” technologies used in DNA sequencing, drug discovery, virus detection and other biomedical applications.

A laboratory-on-a-chip is a device that integrates laboratory functions on a chip that is only millimeters or centimeters in size. The technology allows for the automation and miniaturization of biochemical reactions. It has the potential and to improve and reduce the cost of healthcare.

“If you think of the beginning of computers they were basically tools to automate mathematics,” saidPhilip Brisk, an assistant professor in the Department of Computer Science and Engineering at UC Riverside’s Bourns College of Engineering. “What are we are creating is devices that could automate chemistry in much the same way.”

The most recent laboratory-on-a-chip devices are equipped with integrated electronic sensors, similar in principle to those used in today’s smart phones and tablet PCs. These sensors enable scientists and health care professionals working with the devices to analyze the sensor data to make informed decisions about future analyses to perform.

Brisk and his research team are funneling the sensor data into a computer, facilitating automated decision making, rather than employing a human-in-the-loop.

“We are really trying to eliminate as much human interaction as possible,” Brisk said. “Now, you have a chip, you use it and then you analyze it. Through automation and programmability, you eliminate human error, cuts costs and speed up the entire process.”

Brisk’s findings were recently published in a paper, “Interpreting Assays with Control Flow on Digital Microfluidic Biochips,” in ACM Journal on Emerging Technologies in Computing Systems.

There were two co-authors: Daniel Grissom, one of Brisk’s Ph.D. students; and Christopher Curtis, who worked with Brisk for three years as an undergraduate and plans to return as a Ph.D. student in the fall.

The team started with an existing biological programming language, BioCoder, developed by Microsoft’s research office in India. It was originally created to improve the reproducibility and automation of biology experiments by using a programming language to express the series of steps taken.

The UC Riverside team modified BioCoder to process sensor feedback in real-time. Using a software simulator to mimic the behavior of a laboratory-on-a-chip, they proved it works.  Now, in conjunction withWilliam Grover, an assistant professor of bioengineering at UC Riverside, they plan to build a prototype chip that can be used for real world applications.

This research is supported by the National Science Foundation under grant CNS-1035603, an NSF Graduate Research Fellowship awarded to Grissom, and a UC Riverside Dissertation Year Fellowship, also awarded to Grissom, who completes his Ph.D. in June, 2014.

Brisk was also recently awarded a five-year, $493,645 National Science Foundation CAREER grant for related research to apply semiconductor design automation and layout principles to laboratory-on-a-chip technology.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos